Eli Cahan

Eli Cahan Contributor Share on Twitter Eli Cahan is a medical student at NYU on leave to complete a master’s in health policy at Stanford as a Knight-Hennessey Scholar. His research addresses the effectiveness, economics, and ethics of (digital) health innovation. More posts by this contributor Why key performance indicators are crucial amidst a (public health) crisis How the coronavirus outbreak will stress-test startups

Eli Cahan is a medical student at NYU on leave to complete a master’s in health policy at Stanford as a Knight-Hennessey Scholar. His research addresses the effectiveness, economics, and ethics of (digital) health innovation.

The Latest from Eli Cahan

Why key performance indicators are crucial amidst a (public health) crisis

Day after day, the burden of COVID-19 caused by SARS-CoV-2 mounts further. As of this writing, nearly 400,000 patients worldwide were confirmed for the disease, including over 46,000 cases spanning ev

How the coronavirus outbreak will stress-test startups

The coronavirus pandemic continues to spread with no signs of abating. Over 100,000 cases have been confirmed. Some 4,000 deaths have been reported. 

Will unreliable research bury your healthcare startup?

For healthtech founders and funders, scientific claims and conclusions are more than policy — business models depend upon the lucid appraisal of clinical problems, evaluating inadequacies in current

How healthtech startups can achieve true value

Healthtech is apparently in a golden age. Just a few weeks ago, Livongo and Health Catalyst raised a combined $500 million through IPOs with a joint valuation reaching $3.5 billion...